The surgical technology developer was valued at $3bn in a series C round backed by returning investor Cambridge Innovation Capital.

CMR Surgical, a UK-based surgical robotics technology developer, has raised $600m in a series D round backed by Cambridge Innovation Capital (CIC).
The round, which valued CMR at $3bn, was co-led by telecoms group SoftBank’s Vision Fund 2 and healthcare investment group Ally Bridge.
GE Healthcare, a subsidiary of power and industrial technology conglomerate General Electric, also took part, as did internet company Tencent, RPMI Railpen, Chimera, LGT and its Lightrock affiliate, Watrium and PFM Health Sciences.